4.6 Article

Exposure to Potentially Harmful Drug-Disease Interactions in Older Community-Dwelling Veterans Based on the Healthcare Effectiveness Data and Information Set Quality Measure: Who Is at Risk?

Journal

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
Volume 59, Issue 9, Pages 1673-1678

Publisher

WILEY
DOI: 10.1111/j.1532-5415.2011.03524.x

Keywords

drug disease interaction; HEDIS measures; potentially inappropriate prescribing; aged; pharma-coepidemiology

Funding

  1. VA Health Services Research [IIR-06-062]
  2. National Institute of Aging [R01AG027017, P30AG024827, T32 AG021885, K07AG033174, R01AG034056]
  3. National Institute of Mental Health [R34 MH082682]
  4. National Institute of Nursing Research [R01NR010135]
  5. Agency for Healthcare Research and Quality [R01HS017695]
  6. Geriatric Academic Career Award [KO1 HP00114-02]
  7. VA Health Services Research and Development Service (HSRD) [IIR 06-062]
  8. VA HSRD [IIR-06-062, DHI 09-237, IIR-06-062 PI, PPO 09-295 PI, IIR 02-274 PI, IIR 08-274, SDR-07-042, IIR-05-121, IAF-06-080, IIR-09-335, SHP 08-140, TRX 01-091, RRP 09-112]
  9. Epilepsy Foundation PI
  10. Department of Defense [CDMRP 09090014]
  11. NIH [R01-NR010828]

Ask authors/readers for more resources

OBJECTIVES: To identify prevalence and risk factors for exposure to drug-disease interactions included in the Healthcare Effectiveness Data and Information Set (HEDIS) Drug-Disease Interaction (Rx-DIS) measure. DESIGN: Cross-sectional retrospective database analysis. SETTING: Outpatient clinics within the Department of Veterans Affairs (VA). PARTICIPANTS: Individuals aged 65 and older who received VA outpatient care between October 1, 2003, and September 30, 2006. MEASUREMENTS: Rx-DIS exposure based on the HEDIS measure was identified in VA patients with dementia, falls, and chronic renal failure using VA pharmacy and administrative databases. Factors associated with Rx-DIS exposure were examined, including demographic, health status, and access-to-care factors, including VA outpatient health services use and copayment status. RESULTS: Of the 305,041 older veterans who met criteria for inclusion, the 1-year prevalence of Rx-DIS exposure was 15.2%; prevalence was 20.2% for dementia, 16.2% for falls, and 8.5% for chronic renal failure. Patients with high disease burden (physical, psychiatric, number of medications) were significantly more likely to have Rx-DIS exposure, regardless of condition. Hispanics and individuals with no copayments were more likely to have Rx-DIS exposure than whites or those with required copayments. There was variation in other predictors based on the type of Rx-DIS. CONCLUSION: The prevalence of Rx-DIS was common in older VA outpatients. Future studies should examine the risk of Rx-DIS exposure on health outcomes using separate analyses for each type of Rx-DIS separately before combining all Rx-DIS into a single measure of exposure. Studies that examine the effectiveness of interventions to reduce Rx-DIS exposure will also be helpful in improving the quality of care for older adults. J Am Geriatr Soc 59: 1673-1678, 2011.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available